Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
3(25%)
Results Posted
40%(2 trials)
Terminated
2(17%)

Phase Distribution

Ph phase_1
4
33%
Ph not_applicable
2
17%
Ph phase_3
1
8%
Ph phase_2
4
33%

Phase Distribution

4

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
4(36.4%)
Phase 2Efficacy & side effects
4(36.4%)
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
2(18.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(5)
Terminated(3)
Other(1)

Detailed Status

Completed5
Recruiting2
Terminated2
unknown1
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
71.4%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (36.4%)
Phase 24 (36.4%)
Phase 31 (9.1%)
N/A2 (18.2%)

Trials by Status

unknown18%
withdrawn18%
recruiting217%
active_not_recruiting18%
completed542%
terminated217%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
12